Joint Providership Accreditation and Designation Statement.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Virginia School of Medicine and Bon Secours Cancer Institute.The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Virginia School of Medicine designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Virginia School of Medicine awards hours of participation (equivalent to AMA PRA Category 1 Credit(s)™) to each non-physician participant who successfully completes this educational activity. Bon Secours Cancer Institute maintains a permanent record of participants who have been awarded CEUs.
Primary care physicians, specialists, OB-GYNs, surgeons, medical oncologists, radiation oncologists, nurse practitioners and other healthcare professionals interested in a deeper knowledge and understanding of the full continuum of cancer care including healthy survivorship.
Participants at the end of the summit will be able to:
- Describe strategies for assisting cancer patients to move toward a healthy survivorship
- Discuss the implications for addressing cardio-oncology complications from treatment for the subpopulation for patients who are susceptible
- Articulate the benefits of early lung cancer screening in high risk patients as it relates to population health
- Develop strategies to resolve the challenges of early detection of gastric cancer and the implications for the primary care physician
- Compare the potential improvements in cancer patient care as a result of collaboration between the cancer care team and the palliative care team
- • Develop a plan to overcome the unique challenges that are faced by the geriatric patient
- Explain the newest innovations in breast cancer screening and treatment and the potential advantages to patients
Disclosure of Faculty Financial Affiliations
The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.
The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
All faculty presenters participating in an accredited CME activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.)
The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia.
The following faculty and staff have reported an affiliation to disclose:
- James V. Pellicane, MD—Agendia, Caris Life Sciences
- Hyman Muss, MD —Pfizer, Eisai
The following faculty and staff have no affiliations to disclose:
- Bradley Prestidge, MD
- Darius D. Hollings, MD
- Gary R. Zeevi, MD
- John R. Adler, MD
- Leanne M. Yanni, MD
- Wendy S. Harpham, MD
- William Irvin, Jr., MD
- Steven M. Duffy, MD
- Marybeth S. Hughes, MD
DISCLOSURE OF DISCUSSION OF NON FDA-APPROVED USES FOR PHARMACEUTICAL PRODUCTS AND/OR MEDICAL DEVICES
The University of Virginia School of Medicine, as an ACCME provider, requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The University of Virginia School of Medicine recommends that each physician fully review all the available data on new products or procedures prior to clinical use.
The University of Virginia Office of Continuing Medical Education requires that all participants at live CME activities sign attendance sheets daily to confirm participation in the CME activity for that day.
The Americans Disabilities Act of 1990 requires that all individuals, regardless of their disabilities, have equal access. The Office of Continuing Medical Education at the University of Virginia School of Medicine is pleased to assist participants with special needs. Written requests must be received 30 days prior to the conference date. Please email request to email@example.com or fax to 804-287-7556.